- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About PULSE BIOSCIENCES INC
Pulse Biosciences, Inc. is a novel bioelectric medicine company. The Company's Nano-Pulse Stimulation (NPS) technology platform is designed to send energy pulses to cells in order to alter the function of the internal cellular organelles, including the mitochondria and endoplasmic reticulum, without disrupting extracellular tissue. Its commercial product CellFX System is is designed to function on the basis of a non-thermal mechanism of action in a biophysical disruption brought about by the tunable speed and amplitude of NPS pulses interacting with the physical structure of cells. The CellFX System includes a multi-use handpiece and an initial suite of five single use dermatology treatment tips.
9.69%
5.1%
Stock Analysis
last close
$1.81
1-mo return
-43.1%
3-mo return
-65.3%
avg daily vol.
229.8T
52-week high
29.16
52-week low
1.41
market cap.
$59M
forward pe
-
annual div.
-
roe
-302.4%
ltg forecast
-
dividend yield
-
annual rev.
$2M
inst own.
14.6%
